Plasmodium nucleic acid and protein synthesis machinery

The Plasmodium nucleic acid and protein synthesis machinery represents the collective set of enzymes and organelles responsible for the replication and expression of the malaria parasite's genome. This complex system includes the cytosolic ribosomes, the unique 70S-like ribosomes of the apicoplast, and the enzymes of the folate biosynthesis pathway, which are essential for producing the precursors of DNA and RNA (Source: PubMed, PMID: 15596722). Drugs such as sulfadoxine and pyrimethamine target this machinery by inhibiting dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR), respectively, thereby preventing the synthesis of thymidylate and nucleic acids (Source: WHO Malaria Guidelines). Additionally, antibiotics like doxycycline and clindamycin target the apicoplast's protein synthesis machinery, leading to a delayed death phenotype where the parasite fails to survive the subsequent replication cycle (Source: Nature Reviews Microbiology, "The apicoplast as an antimalarial drug target"). This machinery is a critical therapeutic target because many of its components, particularly those in the apicoplast, are evolutionarily distinct from human counterparts, allowing for selective toxicity. However, the clinical utility of drugs targeting these pathways is increasingly threatened by the emergence of genetic mutations in the parasite that confer high levels of resistance (Source: CDC, Malaria Treatment).

Other names

Plasmodium replication and translation machineryMalarial nucleic acid and protein synthesis pathwaysPlasmodium biosynthetic machinery

Inhibition of dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) to block folate synthesis; inhibition of the 30S or 50S ribosomal subunits to halt protein translation; and interference with DNA replication and RNA transcription.